コンテンツへスキップ
Merck

Interaction of drug based binuclear mixed-ligand complexes with DNA.

Bioorganic & medicinal chemistry (2009-07-08)
Mohan N Patel, Mehulsinh R Chhasatia, Deepen S Gandhi
要旨

Here in we tried to increase an antibacterial activity of ciprofloxacin drug due to formation of mixed-ligand complexes. Synthesized compounds were found to be more potent compare to drugs, ligands and metal salt against selective gram((+ve)) and gram((-ve)) organisms. Interaction of the complexes with nucleic acid (DNA) were investigated using spectroscopic technique, viscosity measurement and gel electrophoresis and it was found that the complexes bind to DNA via intercalative mode.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
o-フェニレンジアミン, flaked, 99.5%
Sigma-Aldrich
レボフロキサシン, 98.0-102.0% anhydrous basis (HPLC)
Sigma-Aldrich
o-フェニレンジアミン, Peroxidase substrate, ≥98.0%, powder
Sigma-Aldrich
オフロキサシン, fluoroquinolone antibiotic
Sigma-Aldrich
エチレンジアミン, purified by redistillation, ≥99.5%
Sigma-Aldrich
エチレンジアミン, ReagentPlus®, ≥99%
Sigma-Aldrich
1,8-ジアミノナフタレン, 99%
Sigma-Aldrich
シプロフロキサシン, ≥98% (HPLC)
Sigma-Aldrich
o-フェニレンジアミン, tablet, 20 mg substrate per tablet
Sigma-Aldrich
エチレンジアミン, BioXtra
Sigma-Aldrich
スパルフロキサシン, ≥98.0% (HPLC)
Sigma-Aldrich
エチレンジアミン 溶液, technical, 75-80%
Sigma-Aldrich
エチレンジアミン, puriss. p.a., absolute, ≥99.5% (GC)
Sigma-Aldrich
エンロフロキサシン, ≥99.0%
Supelco
ノルフロキサシン, analytical standard, ≥98% (TLC)
Supelco
エチレンジアミン, analytical standard
Supelco
エンロフロキサシン, VETRANAL®, analytical standard
Supelco
シプロフロキサシン, VETRANAL®, analytical standard
Sigma-Aldrich
エチレンジアミン, meets USP testing specifications
Supelco
オフロキサシン, VETRANAL®, analytical standard
Supelco
ノルフロキサシン, VETRANAL®, analytical standard